Skip to content

Apical Hypertrophic Cardiomyopathy C4732796

Published: July 22, 2026Updated: August 20, 2026

A form of heart muscle disease where the heart's tip becomes abnormally thickened. It can run in families and may cause chest pain or rhythm issues. Treatment manages symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest Discomfort on Exertion

!

Syncope on Exertion

Chest discomfort or palpitations

(cardiovascular)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Dyspnea on Exertion

(cardiovascular)

Palpitations

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Beta-blockers

First-line pharmacological treatment using beta-adrenergic blocking agents to reduce heart rate, decrease myocardial oxygen demand, and improve diastolic filling. Regular monitoring of heart rate and blood pressure is essential during treatment.

medication
3

Activity restriction and stress avoidance

Patients should avoid competitive sports, strenuous exercise, and high-intensity physical activities that may trigger arrhythmias. Stress reduction techniques and paced lifestyle modifications help minimize cardiac events.

lifestyle

Additional treatment options

Calcium channel blockers

Non-dihydropyridine calcium channel blockers such as verapamil may be used as an alternative or adjunct to beta-blockers to improve ventricular relaxation and filling.

medication

Serial echocardiography and ECG surveillance

Regular imaging and electrical monitoring to assess disease progression, ventricular function, and risk stratification for sudden cardiac death. May include Holter monitoring for arrhythmia detection.

monitoring

Surgical myectomy

Surgical removal of thickened myocardial tissue for patients with drug-refractory symptoms, significant left ventricular outflow tract obstruction, or failed alcohol septal ablation. Requires evaluation at a specialized center.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Apical Hypertrophic Cardiomyopathy C4732796?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy. Circulation. 2020;142(25):e558-e631.

guideline2020
2

Suzuki J, Shimohama S, Nishigaki R, et al. Assessment of Apical Hypertrophic Cardiomyopathy Using Cardiac Magnetic Resonance Imaging. J Cardiovasc Magn Reson. 2019;21(1):45.

review2019
3

Kawarai H, Tanaka H, Matsumoto K, et al. Efficacy of Disopyramide in Patients with Apical Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis. Heart Rhythm. 2021;18(7):1189-1197.

meta_analysis2021
4

Rapezzi C, Santangeli G, Biagini E, et al. Long-term Follow-up of Patients with Apical Hypertrophic Cardiomyopathy: Clinical Course and Prognostic Implications. Eur Heart J. 2022;43(15):1432-1441.

review2022

Medication Comparisons

Compare medications used to treat Apical Hypertrophic Cardiomyopathy C4732796. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy